THE USE OF A PANEL OF URINARY CYTOKINES TO PREDICT RESPONSE TO BCG THERAPY FOR BLADDER CANCER

• 收藏
• 分享

专利权人:

BOARD OF REGENTS; THE UNIVERSITY OF TEXAS SYSTEM

发明人:

KAMAT, ASHISH, M.,BRIGGMAN, JOSEPH,DINNEY, COLIN, P.,URBAUER, DIANA

申请号：

EP13755291

公开号：

EP2819694A4

申请日:

2013.03.04

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

Methods for predicting cancer recurrence following a BCG immunotherapy are provided. In some aspects, cytokine levels from a patient are measured before and after a BCG therapy and the changes in cytokine levels are used to determine the risk of cancer lapse. Methods for selecting a patient for a further anti-cancer therapy are also provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/